Navigation Links
Vermillion and the Ohio State University Report That Novel Diagnostic Test May Help Predict Risk for Relapse of TTP, A Serious Blood Disorder
Date:4/24/2008

commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its prestigious scientific collaborators, has diagnostic programs in oncology, hematology, cardiology and women's health. Vermillion is based in Fremont, California. Additional information about Vermillion can be found on the Web at http://www.vermillion.com.

Forward Looking Statements

This news release contains forward-looking statements that involve significant risks and uncertainties, including statements regarding Vermillion's plans, objectives, expectations and intentions. These forward- looking statements are based on Vermillion's current expectations. The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for such forward-looking statements. In order to comply with the terms of the safe harbor, Vermillion notes that a variety of factors could cause actual results and experience to differ materially from the anticipated results or other expectations expressed in such forward-looking statements. There are no guarantees that Vermillion will succeed in its efforts to commercialize TTP diagnostic products in 2008 or during any other period of time. Factors that could cause actual results to materially differ include but are not limited to: (1) uncertainty in obtaining intellectual property protection for inventions made by Vermillion; (2) unproven ability of Vermillion to discover, develop, and commercialize TTP diagnostic products based on findings from its disease association studies; (3) unproven ability of Vermillion to discover or identify new protein biomarkers and use such information to develop TTP diagnostic products; (4) uncertainty as to whether Vermillion will be able to obtain any required regulatory approval of its TTP diagnostic products; (5) uncertainty of market acceptance of its TTP diagnostic products, inclu
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
2. Vermillion Receives Award From the Society of Gynecologic Oncologists
3. Free Prostate Cancer Seminar in Lake Ridge, VA: Dr. Charles Snuffy Myers Announces Vitamin D Clinical Trials
4. Medarex Reports Interim Data from Ongoing Ipilimumab Combination Phase 1 Studies in Prostate Cancer at American Association for Cancer Research Meeting
5. Halozyme Therapeutics Presents Pre-Clinical Studies of Systemic Delivery of Pegylated rHuPH20 Enyzme in Prostate Cancer Models at American Association for Cancer Research Conference
6. Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95% and Halts Metastasis in a Model of Hormone-Refractory Prostate Cancer
7. SuperGens MP-470 Sensitizes Prostate and Breast Cancer Cells to Erlotinib
8. Microwave Treatments for Enlarged Prostate Cause Blood Pressure Surges
9. Wayne State University and Oakwood Partner in New Device to Combat Congestive Heart Failure
10. Columbia University Medical Center and Rosetta Genomics Announce Columbia Universitys Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica
11. Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... 2014  Decision Resources Group,s new Manhattan ... that online information and other value-added services ... their offering and support physicians. Physicians who ... rely on websites, mobile apps and other ... physicians are looking to manufacturers to provide ...
(Date:9/15/2014)... -- The Society of Corporate Compliance and Ethics ... 4,500 compliance and ethics professionals from across industry, ... fines and settlements.  The SCALENDAR is designed to ... reference to demonstrate to employees the consequences of ... help compliance and ethics officers looking for a ...
(Date:9/15/2014)... Sept. 15, 2014 Research and Markets ... for In Vitro Diagnostic Tests, 9th Edition" report to ... entirety of the clinical testing market and all of its ... by Top IVD Companies For Business Planning. This ... the market events of 2013 and early 2014. New entrants, ...
Breaking Medicine Technology:Physician device decision-makers show strong demand for device manufacturer digital content and support 2Physician device decision-makers show strong demand for device manufacturer digital content and support 3More than $55 billion in fines and settlements added by SCCE to its 2015 Corporate Scandal Calendar 2The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition 2The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition 3
... Goodrich Corporation (NYSE: GR ) at next ... real-time information to air crews and lower operating costs ... Heli-Expo 2011 takes place at the Orange County Convention ... Goodrich (booth 2142) will display its HUMS (Health ...
... Therapeutics Inc. (TSX: NPC), today announced that Gordon C. ... , March 3rd, 2011TIME: , 3:00 PM ESTLINK: ... online event where investors are invited to ask the ... as well as the company,s "virtual trade booth." If ...
Cached Medicine Technology:Goodrich to Showcase Advanced Helicopter Systems at Heli-Expo 2Allon Therapeutics to Present Live, Online at RetailInvestorConferences.com on March 3rd 2Allon Therapeutics to Present Live, Online at RetailInvestorConferences.com on March 3rd 3
(Date:9/15/2014)... Club wear is provocative, revealing, or fetish ... with a very relaxed dress code. There are various types ... on the location of the club, the club's dress code ... and retailer, has delightedly pronounced its new series of delicate ... low prices. , A nightclub (also known as a discothèque, ...
(Date:9/15/2014)... 2014 1Heart Caregiver Services Training ... staff of Regency Park Oak Knoll during the ... Executive Director Gladys Broxton. This continuing professional education ... 1Heart Shirley Billedo and Regency Park officers of ... Jeanine Hernandez and Activities Coordinator Alfonso Escalante. , ...
(Date:9/15/2014)... BROOK, Ill. (PRWEB) September 15, 2014 ... at risk for stroke who might benefit from aggressive ... in the journal Radiology. , The study looked ... of the major blood vessels supplying blood to the ... stenosis is the primary cause of up to 20 ...
(Date:9/15/2014)... neuroscience researchers at the University of Copenhagen have ... cause Parkinson,s disease. The findings have recently been ... . , The defining symptoms of Parkinson,s ... There is currently no cure for the condition, ... with the potential to shed some light on ...
(Date:9/15/2014)... 15, 2014 Today, Zane Benefits, the ... Bank’s Speaking on Business radio show. , According ... so employers know it doesn’t make sense to choose ... also save the employer and employee as much as ... of Zions Bank's Speaking on Business , Chris ...
Breaking Medicine News(10 mins):Health News:Delicate Club Wears Are For Sale At Fecbek.com 2Health News:1Heart Caregiver Services Training Director Randolph Neil Conducted In-Service Training at Regency Park Oak Knoll Pasadena 2Health News:1Heart Caregiver Services Training Director Randolph Neil Conducted In-Service Training at Regency Park Oak Knoll Pasadena 3Health News:1Heart Caregiver Services Training Director Randolph Neil Conducted In-Service Training at Regency Park Oak Knoll Pasadena 4Health News:RSNA: Imaging Identifies Asymptomatic People at Risk for Stroke 2Health News:RSNA: Imaging Identifies Asymptomatic People at Risk for Stroke 3Health News:Researchers debunk myth about Parkinson's disease 2Health News:Zane Benefits Featured on Zions Bank Speaking on Business 2
... Oregon Health & Science University,s Vaccine and Gene Therapy Institute ... of infection before it becomes a rapidly replicating, ... the spread of the disease. The research is published in ... and will appear in a future printed edition. ...
... Bob Woodruff was injured while reporting in Iraq in 2006, ... his ability to recall and produce common words a ... language skills thanks to intensive behavioral therapy reading and ... for patients with aphasia has always been and will always ...
... Martek Biosciences Corporation (Nasdaq: MATK ) announced ... quarter of fiscal 2009 on March 4, 2009, at approximately ... 4:45 p.m. ET Martek will conduct a conference call to ... listen to the call live via webcast by visiting Martek,s ...
... but not available in U.S., was stopped early due ... -- A large study of tibolone, a drug used ... halted early after researchers found that the synthetic steroid ... survivors of the disease. , Tibolone isn,t available in ...
... Patient Check-In Company(TM), the leader in patient-intake, announced ... bringing total investment to date to $25 million. ... fund of the BlueCross BlueShield Association, and Sandbox ... Venture Partners, HLM Venture Partners, and Long River ...
... pathway that is responsible for generating excess connective tissue ... human patients with scleroderma. The study, published by Cell ... Developmental Cell , also reveals an intriguing but unexpected ... disease. , Platelet derived growth factors (PDGF) regulate ...
Cached Medicine News:Health News:OHSU vaccine research targets HIV in the slower, early stage of infection 2Health News:Exploring new pathways to language 2Health News:Menopause Drug Tied to Breast Cancer Recurrence 2Health News:Phreesia Secures $11.6M Series C Funding Led by BlueCross BlueShield Venture Partners and Sandbox Industries 2Health News:Phreesia Secures $11.6M Series C Funding Led by BlueCross BlueShield Venture Partners and Sandbox Industries 3Health News:Phreesia Secures $11.6M Series C Funding Led by BlueCross BlueShield Venture Partners and Sandbox Industries 4Health News:Tumor suppressor may attenuate fibrotic disease 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: